SLS
Sellas Life Sciences Group, Inc.
$4.77-0.11 (-2.25%)
Price
MA20
▲Insider buy
▼Insider sell
Loading chart...
🤖 AI InsightHaiku 4.5
Galena Biopharma, Inc. (GALE) is a publicly traded company with no SEC Form 4 insider transactions reported in the past 90 days. Form 4 filings disclose insider stock activity within two business days. The absence of recent filings can reflect either a stable insider holding pattern or simply no recent transactions to report. Historical filings, if any, remain searchable below.
Latest Insider Transactions
Showing 10 of 14 transactions (past 365 days)
| 1WStock price change 1 week after insider bought. Small number below shows return vs S&P 500. | 1MStock price change 1 month after insider bought. | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 2026-01-09 | 2026-01-07 | Cicic Dragan | CDO | Award | 300,000 | $0.00 | $0 | N/A | N/A |
| 2026-01-09 | 2026-01-07 | Van Nostrand Robert L | Director | Award | 50,000 | $0.00 | $0 | N/A | N/A |
| 2026-01-09 | 2026-01-07 | Wasman Jane | Director | Award | 50,000 | $0.00 | $0 | N/A | N/A |
| 2026-01-09 | 2026-01-07 | Scheinberg David A | Director | Award | 50,000 | $0.00 | $0 | N/A | N/A |
| 2026-01-09 | 2026-01-07 | Burns John Thomas | CFO | Award | 300,000 | $0.00 | $0 | N/A | N/A |
| 2026-01-09 | 2026-01-07 | Varian John | Director | Award | 50,000 | $0.00 | $0 | N/A | N/A |
| 2026-01-09 | 2026-01-07 | Kalin Katherine Bach | Director | Award | 50,000 | $0.00 | $0 | N/A | N/A |
| 2025-12-05 | 2025-12-03 | Stergiou Angelos M. | CEO | Other | 187,066 | $1.50 | -$280,599 | N/A | N/A |
| 2025-12-05 | 2025-12-03 | Burns John Thomas | CFO | Other | 58,592 | $1.50 | -$87,888 | N/A | N/A |
| 2025-12-05 | 2025-12-03 | Cicic Dragan | CDO | Other | 63,800 | $1.50 | -$95,700 | N/A | N/A |
Want to see more transactions?
Sign up for free to unlock more insider transactions and create watchlists.